COMP <GO>
ITOC vs ABBV // GROSS PROFIT MARGIN
iTonic Holdings Ltd (Class A) (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: ITOC 2
— ABBV 9
▲ GROSS PROFIT MARGIN LEADER: ABBV
LAST: $2.85 (-4.99%) • MKT CAP: $20.9M
gross-margins
62.60%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
gross-margins
70.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ITOC VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ITOC | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 62.60% | 70.20% | -7.60 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 29.00% | -64.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -15.52% | 3.47% | -18.99 | ABBV | /fcf-yield <GO> |
| Operating Margin | -60.00% | 24.60% | -84.60 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 6.90% | -66.90 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 16.70% | 8.60% | +8.10 | ITOC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.04% | 2.27% | -2.23 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.69 | 5.33 | +5.36 | ITOC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.9 | 65.1 | -32.20 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.9M | $513.86B | -$513.84B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ITOC REV | ABBV REV | ITOC GROSS % | ABBV GROSS % | ITOC FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $523.0K | $61.16B | 62.6% | 70.2% | -$3.2M | $17.82B |
| FY 2024 | $448.2K | $56.33B | 85.0% | 70.0% | -$775.9K | $17.83B |
| FY 2023 | $628.6K | $54.32B | — | — | -$63.6K | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ITOC // BETA —
ABBV // BETA 1.15